← Eichor
Study identifier: NCT06311890 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Study to Evaluate the Efficacy, Safety and Tolerability of Photodynamic Therapy(PDT) With Chlorin-e6 in Treating Moderate to Severe Acne

Condition: Acne · Photodynamic Therapy  ·  Sponsor: Xiyuan Hospital of China Academy of Chinese Medical Sciences

PhasePhase 2
Planned participants46
Who can joinAll sexes, 18 Years to 50 Years
Healthy volunteersNo

About this study

This study aims to evaluate the clinical efficacy, safety and tolerability of a photodynamic therapy(PDT) based on a new photosensitizer, Chlorin-e6, in the treatment of moderate to severe acne. The hypothesis is that the therapy has good efficacy, safety and tolerability.

This description comes directly from the study's public registry record.

Talk to the study team

Huiyan Chi, doctor  ·  13811626953  ·  chihuiyan@163.com

Yisheng Zhang, doctor  ·  15652386117  ·  llleera@126.com

Always discuss trial participation with your own doctor first.

Locations (1)

Xiyuan Hospital of China Academy of Chinese Medical Sciences OrganizationBeijing, ChinaRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06311890